Dutch enforcer reduces first-ever excessive pricing fine after appeal
Pharmaceutical company Leadiant Biosciences has successfully convinced the Dutch competition authority to lower its first-ever excessive pricing fine.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.